Log In
Print this Print this

secnidazole (Solosec) (formerly SYM-1219)

  Manage Alerts
Collapse Summary General Information
Company Symbiomix Therapeutics LLC
DescriptionGranule formulation of a next-generation, 5-nitroimidazole antibiotic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationBacterial vaginosis
Indication DetailsTreat bacterial vaginosis
Regulatory Designation U.S. - Fast Track (Treat bacterial vaginosis);
U.S. - Qualified Infectious Disease Program (Treat bacterial vaginosis)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today